Krka Spells Out Chinese Potential With Plans To Double Portfolio In 2022

Slovenian Firm Also Plans To Regroup In West Europe After 11% Sales Tumble

Alongside discussing the firm’s preliminary financial results for 2021, Krka management explained how the company planned to make further inroads in China in 2022 and return to its 2020 revenue baseline in West Europe, following a dip last year.

China growth
Krka launched pregabalin in China in 2021 • Source: Shutterstock

More from Earnings

More from Business